Beloflux 5 mg filmom obložene tablete
| Name | Beloflux 5 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-687853542 |
| Active Substance | solifenacinsukcinat |
| Composition | jedna filmom obložena tableta sadrži 5 mg solifenacinsukcinata što odgovara 3,8 mg solifenacina |
| Pharmaceutical Form | filmom obložena tableta |
| Packaging [MA Number for Packaging] | 30 tableta u blisteru, u kutiji [HR-H-687853542-01] 90 tableta u blisteru, u kutiji [HR-H-687853542-02] |
| Manufacturer | Belupo lijekovi i kozmetika d.d., Koprivnica, Hrvatska |
| Marketing Authorisation Holder | Belupo lijekovi i kozmetika d.d., Ulica Danica 5, Koprivnica, Hrvatska |
| Marketing Authorisation Date | 08.09.2023 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/23-02/87 |
| Registration Number | 381-12-01/154-23-04 |
| Prescription | na recept |
| Type of prescription | ponovljivi recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | G04BD08 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
